How to prepare Your QMS for IVDR and ISO 13485 — Without Drowning in Work
As medical device regulations evolve, paper-based or fragmented quality systems can no longer keep up. Companies today face stricter compliance demands under the medical device regulations aundespite where in the world the medical device is to be sold.
As medical device regulations evolve, paper-based or fragmented quality systems can’t keep up. Companies face stricter compliance demands under EU MDR and ISO 13485—regardless of where the device will be marketed. An Electronic Quality Management System (EQMS) provides centralized control, traceability, and audit readiness across the entire product lifecycle.
Yet, with the right tools and structure, compliance doesn’t have to mean complexity.
An EQMS is a digital platform that centralizes all quality processes and documentation within an organization. Instead of relying on scattered spreadsheets, PDFs, or local folders, an EQMS integrates all quality-related data—from procedures and CAPAs to risk and design control—into one secure, audit-ready system.
The result is a transparent, traceable environment where quality and compliance are no longer reactive—they are embedded into daily operations.
For medical device manufacturers, quality is not just about efficiency—it’s a regulatory requirement. MDR and ISO 13485 require an auditable QMS with strict documentation, traceability, and risk control. An EQMS helps organizations:
Consider a Class IIa device manufacturer preparing an MDR technical documentation submission. With a manual QMS, the team may spend weeks locating procedures, validation evidence, and risk files. Using MedQdoc, all records are digitally linked to the applicable clause and version, enabling demonstration of compliance in minutes—not days.
The EU Medical Device Regulation (EU MDR 2017/745) defines detailed requirements to ensure device safety, performance, and continuous oversight. Under Article 10, manufacturers must establish, document, implement, and maintain a QMS that covers design, risk, clinical evaluation, production, and post-market activities.
An EQMS like MedQdoc provides the digital infrastructure to meet these obligations—linking procedures, records, and traceability requirements in an audit-ready way.
Annex I sets the essential safety and performance requirements every device must meet, including biological safety, risk control, labeling, and usability.
An EQMS centralizes risk assessments, verification results, and usability studies under structured templates, ensuring all GSPR clauses are fulfilled and linked to technical documentation.
Annex II specifies the structure and content of the technical documentation that demonstrates conformity with MDR and must be kept up to date throughout the lifecycle.
With MedQdoc, manufacturers manage and version-control all Annex II elements digitally, linking procedures, validation records, and clinical evidence files.
Annex III requires a PMS system proportionate to the device risk class to continuously collect and analyze performance and safety data after market placement.
An EQMS integrates CAPA, complaint handling, and audit tracking so PMS data feeds directly into risk management and management review—closing the compliance loop.
Annex XIV defines how manufacturers demonstrate clinical performance and safety and outlines continuous post-market clinical follow-up (PMCF).
MedQdoc helps maintain an up-to-date CE documentation trail by linking each evaluation step to design, risk, and PMS records—ensuring full traceability from clinical data to post-market actions.
See MedQdoc in action. Book a short demo to learn how we streamline MDR and ISO 13485 compliance.
ISO 13485 emphasizes documentation control, traceability, and continuous improvement. An EQMS supports these principles by maintaining complete lifecycle records and linking every change or CAPA to the relevant procedure and risk file.
Organizations that rely on traditional, paper-based QMS often face:
Beyond these challenges, maintaining a manual QMS is extremely time-consuming and resource-demanding. Teams spend countless hours locating the latest document versions, chasing approvals, and preparing audit evidence. This diverts key personnel from innovation and increases the risk of non-compliance when processes rely on human diligence rather than automation.
Most MedQdoc customers go live within 4–8 weeks using the platform’s ready-made QMS structure. The system includes pre-approved templates and validation documentation to accelerate deployment in regulated environments.
Contact us to see how MedQdoc simplifies MDR and ISO 13485 compliance through a validated EQMS platform.
Book a demo1. Is an EQMS mandatory under MDR or ISO 13485?
No, an EQMS is not legally mandatory, but it is highly recommended. Both MDR and ISO 13485 require that manufacturers maintain a controlled, traceable, and auditable Quality Management System (QMS). An EQMS provides the digital framework to meet these requirements efficiently and reliably.
2. How secure is an EQMS like MedQdoc?
MedQdoc is a cloud-based, validated EQMS designed specifically for regulated medical device companies. It includes secure user access control, digital signatures, encrypted storage, and a complete audit trail for every action — all compliant with GDPR and EU data protection standards.
3. How long does it take to implement an EQMS?
Implementation typically takes between 4–8 weeks, depending on company size and process maturity. With MedQdoc’s preconfigured MDR and ISO 13485 templates, most customers go live quickly, minimizing validation effort and disruption.
4. Can an EQMS help with FDA compliance as well?
Yes. While MedQdoc is purpose-built for MDR and ISO 13485 compliance, it also supports FDA 21 CFR Part 820 (Quality System Regulation) and Part 11 (electronic signatures). This makes it an ideal global solution for companies that market in both the EU and the US.
5. What are the biggest advantages compared to a manual QMS?
An EQMS eliminates manual, paper-heavy processes and replaces them with automation, visibility, and traceability. Teams save time on document control, CAPA management, and audit preparation, freeing resources for innovation and market expansion. In many cases, organizations see a 30–50% reduction in administrative QMS effort within the first year of EQMS adoption.